835 articles
Jeff Stark, Head of US Medical Immunology at UCB, discusses new long-term complete skin clearance data for bimekizumab in the treatment of moderate to s...
Michael Irizarry, MD, MPH, Senior Vice President, Clinical Research and Deputy Chief Clinical Officer of the Neurology Business Group at Eisai Inc.
Mark Berman, Chief Medical Officer of Better Therapeutics discusses how prescription digital therapeutics (PDTs) could reimagine how we treat type 2 dia...
Angela Carroll, US Medical Affairs Scientific Director-Immuno-inflammation at GlaxoSmithKline (GSK), a global health care company, discusses...
Jack DiPalma, a gastroenterologist at the University of South Alabama College of Medicine and medical director for Braintree Laboratories discusses colo...
Samilia Obeng-Gyasi, MD, MPH, surgical oncologists from The Ohio State University Comprehensive Cancer Center - Arthur G.
Neil Skolnik, MD, Professor of Family and Community Medicine at Jefferson Health and practicing primary care physician discusses chronic kidney disease ...
is a Senior Director, Global Compound Development Team Leader for the Neuroscience Therapeutic Area at Janssen Research & Development, LLC.
Afsaneh Barzi, MD, PhD, associate professor of gastrointestinal oncology at City of Hope discusses advancements in treating colorectal cancer (CRC), esp...
Neely Mozaffarian, M.D., Ph.D., is a Vice President and Autoantibody Pathway Area Leader for the Immunology Therapeutic Area at Janssen Research & Devel...